Handa Pharmaceuticals, Inc.

Handa Pharmaceuticals, Inc.verified

6620.TWO

Price:

$83

Market Cap:

$13.08B

Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027, an oncology products. In addition, the company develops HND-004, a diabetic drug; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pha...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-12-30

Stock Exchange

TWO

Ticker

6620.TWO

The ROE as of July 2025 (TTM) for Handa Pharmaceuticals, Inc. (6620.TWO) is 10.90%

According to Handa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 10.90%. This represents a change of 167.34% compared to the average of 4.08% of the last 4 quarters.

Handa Pharmaceuticals, Inc. (6620.TWO) Historical ROE (quarterly & annually)

How has 6620.TWO ROE performed in the past?

The mean historical ROE of Handa Pharmaceuticals, Inc. over the last ten years is -11.64%. The current 10.90% ROE has changed -193.63% with respect to the historical average. Over the past ten years (40 quarters), 6620.TWO's ROE was at its highest in in the March 2023 quarter at 25.43%. The ROE was at its lowest in in the December 2023 quarter at 3.15%.

Quarterly (TTM)
Annual

Average

-11.64%

Median

-2.77%

Minimum

-53.48%

Maximum

26.37%

Handa Pharmaceuticals, Inc. (6620.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Handa Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.18%

Maximum Annual ROE = 26.37%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -53.48%

Quarterly (TTM)
Annual
YearROEChange
202415.17%-42.49%
202326.37%-575.30%
2022-5.55%-89.63%
2021-53.48%2.18%
2020-52.34%-Infinity%

Handa Pharmaceuticals, Inc. (6620.TWO) Average ROE

How has 6620.TWO ROE performed in the past?

The current ROE of Handa Pharmaceuticals, Inc. (6620.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

12.00%

5-year avg

-13.97%

10-year avg

-11.64%

Handa Pharmaceuticals, Inc. (6620.TWO) ROE vs. Peers

How is 6620.TWO’s ROE compared to its peers?

Handa Pharmaceuticals, Inc.’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Handa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Handa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Handa Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for Handa Pharmaceuticals, Inc. (6620.TWO)?

What is the highest ROE for Handa Pharmaceuticals, Inc. (6620.TWO)?

What is the 3-year average ROE for Handa Pharmaceuticals, Inc. (6620.TWO)?

What is the 5-year average ROE for Handa Pharmaceuticals, Inc. (6620.TWO)?

How does the current ROE for Handa Pharmaceuticals, Inc. (6620.TWO) compare to its historical average?